Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer

Nature Clinical Practice Oncology volume 5, pages 438–439 (2008)Cite this article

Artinyan A et al. (2008) Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment. Cancer 112: 34–42

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Klinkenbijl J et al. (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg 230: 776–782

    Article  CAS  Google Scholar 

  2. Kalser M and Ellengerg S (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899–903

    Article  CAS  Google Scholar 

  3. Neoptolemos J et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200–1210

    Article  CAS  Google Scholar 

  4. Abrams R et al. (2006) RTOG 9704-radiotherapy quality assurance (QA) review and survival. Int J Radiat Oncol Biol Phys 66 (Suppl 1): S22

    Article  Google Scholar 

  5. Hazard L et al. (2007) Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Cancer 110: 2191–2201

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. and DC Shrieve is Professor and Chair of the Department of Radiation Oncology at the Huntsman Cancer Hospital, LJ Hazard is an Assistant Professor, JD Tward is a Resident, University of Utah School of Medicine, Salt Lake City, UT, USA.,

    Lisa J Hazard, Jonathan D Tward & Dennis C Shrieve

Authors
  1. Lisa J Hazard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan D Tward
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dennis C Shrieve
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa J Hazard.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hazard, L., Tward, J. & Shrieve, D. Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer. Nat Rev Clin Oncol 5, 438–439 (2008). https://doi.org/10.1038/ncponc1163

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1163

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing